Dermal and ocular irritation and skin sensitization studies of fullerene C60 nanoparticles

Cutaneous and Ocular Toxicology

Volumn 32, Issue 2, 2013, Pages 128-134

  Ema, Makoto ^a   Matsuda, Akitaka ^b   Kobayashi, Norihiro ^a   Naya, Masato ^a   Nakanishi, Junko ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b N   (Japan)

Author keywords

C60; Dermal irritation; Eye irritation; Fullerenes; Nanomaterials; Nanoparticles; Skin sensitization

Indexed keywords

FULLERENE; NANOPARTICLE;

ANIMAL EXPERIMENT; ARTICLE; CHEMOSIS; CONTROLLED STUDY; CORNEA OPACITY; EDEMA; ERYTHEMA; EXPERIMENTAL GUINEA PIG; EXPERIMENTAL RABBIT; EYE IRRITATION; IRIS DISEASE; MALE; NONHUMAN; SKIN IRRITATION; SKIN SENSITIZATION; WEIGHT GAIN;

ANIMALS; CONSUMER PRODUCT SAFETY; EYE; FULLERENES; GUINEA PIGS; IRRITANTS; MALE; RABBITS; SKIN; SKIN TESTS;

CAVIA; ORYCTOLAGUS CUNICULUS;

EID: 84869441992     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2012.727937     Document Type: Article

References (40)

1. ISO (International Organization for Standardization).
2. Nanotechnologies-terminology and definitions for nanoobjectsnanoparticle, nanofiber and nanoplate. ISO/TS 27687. 2008
3. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K et al.; ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol 2005;2:8
4. Liu WT. Nanoparticles and their biological and environmental applications. J Biosci Bioeng 2006;102:1-7
5. ENRHES (Engineered Nanoparticles: Review of Health and Environmental Safety). Available at: Http://ihcp.jrc.ec.europa.eu/ whats-new/enhres-final- report. Accessed on 10 January 2012
6. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113:823-839 (Pubitemid 40984181)
7. Aschberger K, Johnston HJ, Stone V, Aitken RJ, Tran CL, Hankin SM et al. Review of fullerene toxicity and exposure-appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol 2010;58:455-473
8. Johnston HJ, Hutchison GR, Christensen FM, Aschberger K, Stone V. The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. Toxicol Sci 2010;114:162-182
9. Murray AR, Kisin E, Leonard SS, Young SH, Kommineni C, Kagan VE et al. Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes. Toxicology 2009;257:161-171
10. Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 2007;171:99-110 (Pubitemid 47058824)
11. Ema M, Matsuda A, Kobayashi N, Naya M, Nakanishi J. Evaluation of dermal and eye irritation and skin sensitization due to carbon nanotubes. Regul Toxicol Pharmacol 2011;61:276-281
12. Huczko A, Lange H, Calko E. Fullerenes: Experimental evidence for a null risk of skin irritation and allergy. Full Sci Tech 1999;7:935-939
13. Huczko A, Lange H. Carbon nanotubes: Experimental evidence for a null risk of skin irritation and allergy. Full Sci Tech 2001;9:247-250 (Pubitemid 32697618)
14. Aoshima H, Saitoh Y, Ito S, Yamana S, Miwa N. Safety evaluation of highly purified fullerenes (HPFs): Based on screening of eye and skin damage. J Toxicol Sci 2009;34:555-562
15. Brunauer S, Emmett PH, Teller E. Absorption of gasses in multimolecular layers. J Am Chem Soc 1938;60:309-319
16. Said T, Dutot M, Christon R, Beaudeux JL, Martin C, Warnet JM et al. Benefits and side effects of different vegetable oil vectors on apoptosis, oxidative stress, and P2X7 cell death receptor activation. Invest Ophthalmol Vis Sci 2007;48:5000-5006 (Pubitemid 351260909)
17. Stevens MA. Use of the albino guinea-pig to detect the skinsensitizing ability of chemicals. Br J Ind Med 1967;24:189-202
18. OECD (Organisation for Economic Co-operation and Development Acute dermal irritation/corrosion (Test No. 404, Adopted on 24 April, 2002), OECD guidelines for testing of chemicals. 2002
19. OECD (Organisation for Economic Co-operation and Development).
20. Acute eye irritation/corrosion (Test No. 405, Adopted on 24 April, 2002), OECD guidelines for testing of chemicals. 2002
21. McDonald TO, Shadduck JA. Eyeirritation. In: Marzulli FN, Maibach HI, eds. Dermatoxicology and Pharmacology. Vol. 4. Advances in Modern Toxicology. New York: John Wiley and Sons. 1977, 139-191
22. OECD (Organisation for Economic Co-operation and Development). Skin sensitisation (Test No. 406, Adopted on 17 July, 1992), OECD guidelines for testing of chemicals. 1992
23. Buehler EV. Delayed contact hypersensitivity in the guinea pig. Arch Dermatol 1965;91:171-177
24. Magnusson B, Kligman AM. The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol 1969;52:268-276
25. Kishore AS, Surekha P, Murthy PB. Assessment of the dermal and ocular irritation potential of multi-walled carbon nanotubes by using in vitro and in vivo methods. Toxicol Lett 2009;191:268-274
26. Miyawaki J, Yudasaka M, Azami T, Kubo Y, Iijima S. Toxicity of single-walled carbon nanohorns. ACS Nano 2008;2:213-226 (Pubitemid 351595974)
27. Vittorio O, Raffa V, Cuschieri A. Influence of purity and surface oxidation on cytotoxicity of multiwalled carbon nanotubes with human neuroblastoma cells. Nanomedicine 2009;5:424-431
28. Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005;155:377-384 (Pubitemid 40093001)
29. Rouse JG, Yang J, Barron AR, Monteiro-Riviere NA. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol In Vitro 2006;20:1313-1320 (Pubitemid 44537654)
30. Markovic Z, Todorovic-Markovic B, Kleut D, Nikolic N, Vranjes- Djuric S, Misirkic M et al. The mechanism of cell-damaging reactive oxygen generation by colloidal fullerenes. Biomaterials 2007;28:5437-5448 (Pubitemid 47603199)
31. Zhao B, Bilski PJ, He YY, Feng L, Chignell CF. Photo-induced reactive oxygen species generation by different water-soluble fullerenes © and their cytotoxicity in human keratinocytes. Photochem Photobiol 2008;84:1215-1223
32. Zhao B, He YY, Bilski PJ, Chignell CF. Pristine (C60) and hydroxylated [C60(OH)24] fullerene phototoxicity towards HaCaT keratinocytes: Type I vs type II mechanisms. Chem Res Toxicol 2008;21:1056-1063
33. Shimizu T, Aioi A, Horiguchi T, Kuriyama K. Effect of vitamin E on keratinocyte-modulation induced by lauroylsarcosine. Jpn J Pharmacol 1995;67:291-295
34. Welss T, Basketter DA, Schröder KR. In vitro skin irritation: Facts and future. State of the art review of mechanisms and models. Toxicol In Vitro 2004;18:231-243 (Pubitemid 38376355)
35. Sayes CM, Gobin AM, Ausman KD, Mendez J, West JL, Colvin VL. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 2005;26:7587-7595 (Pubitemid 41187558)
36. Kato S, Aoshima H, Saitoh Y, Miwa N. Biological safety of LipoFullerene composed of squalane and fullerene-C60 upon mutagenesis, photocytotoxicity, and permeability into the human skin tissue. Basic Clin Pharmacol Toxicol 2009;104:483-487
37. Xia XR, Monteiro-Riviere NA, Riviere JE. Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents. Toxicol Appl Pharmacol 2010;242:29-37
38. Green S, Chambers WA, Gupta KC, Hill RN, Hurley PM, Lambert LA et al. Criteria for in vitro alternatives for the eye irritation test. Food Chem Toxicol 1993;31:81-85 (Pubitemid 23085006)
39. Zhao B, He YY, Chignell CF, Yin JJ, Andley U, Roberts JE. Difference in phototoxicity of cyclodextrin complexed fullerene [(gamma- CyD)2/C60] and its aggregated derivatives toward human lens epithelial cells. Chem Res Toxicol 2009;22:660-667
40. Kolosnjaj J, Szwarc H, Moussa F. Toxicity studies of fullerenes and derivatives. Adv Exp Med Biol 2007;620:168-180